vs
Side-by-side financial comparison of OSR Holdings, Inc. (OSRH) and Picard Medical, Inc. (PMI). Click either name above to swap in a different company.
Picard Medical, Inc. is the larger business by last-quarter revenue ($1.2M vs $627.7K, roughly 1.9× OSR Holdings, Inc.). OSR Holdings, Inc. runs the higher net margin — -508.9% vs -878.3%, a 369.4% gap on every dollar of revenue.
OSRH vs PMI — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $627.7K | $1.2M |
| Net Profit | $-3.2M | $-10.4M |
| Gross Margin | 41.7% | -11.0% |
| Operating Margin | -605.9% | -293.8% |
| Net Margin | -508.9% | -878.3% |
| Revenue YoY | -23.7% | — |
| Net Profit YoY | -1283.3% | — |
| EPS (diluted) | $0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $627.7K | $1.2M | ||
| Q2 25 | $1.1M | $2.1M | ||
| Q1 25 | $761.3K | — | ||
| Q3 24 | $823.0K | — | ||
| Q2 24 | $881.8K | — | ||
| Q1 24 | $910.2K | — |
| Q3 25 | $-3.2M | $-10.4M | ||
| Q2 25 | $-5.2M | $-6.7M | ||
| Q1 25 | $-11.4M | — | ||
| Q3 24 | $-231.0K | — | ||
| Q2 24 | $-97.3K | — | ||
| Q1 24 | $-60.4K | — |
| Q3 25 | 41.7% | -11.0% | ||
| Q2 25 | 2.9% | -6.0% | ||
| Q1 25 | 22.2% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 26.3% | — | ||
| Q1 24 | 26.3% | — |
| Q3 25 | -605.9% | -293.8% | ||
| Q2 25 | -460.5% | -165.2% | ||
| Q1 25 | -383.3% | — | ||
| Q3 24 | -433.4% | — | ||
| Q2 24 | -364.0% | — | ||
| Q1 24 | -362.8% | — |
| Q3 25 | -508.9% | -878.3% | ||
| Q2 25 | -460.2% | -315.5% | ||
| Q1 25 | -1496.5% | — | ||
| Q3 24 | -28.1% | — | ||
| Q2 24 | -11.0% | — | ||
| Q1 24 | -6.6% | — |
| Q3 25 | $0.12 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $-0.02 | — | ||
| Q1 24 | $-0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $2.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $134.2M | $8.0M |
| Total Assets | $177.3M | $13.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $2.2M | $2.8M | ||
| Q2 25 | $1.6M | $410.0K | ||
| Q1 25 | $1.6M | — | ||
| Q3 24 | $12.2K | — | ||
| Q2 24 | $119.1K | — | ||
| Q1 24 | $3.6K | — |
| Q3 25 | $134.2M | $8.0M | ||
| Q2 25 | $139.2M | $-54.5M | ||
| Q1 25 | $132.3M | — | ||
| Q3 24 | $-5.8M | — | ||
| Q2 24 | $-4.9M | — | ||
| Q1 24 | $-4.3M | — |
| Q3 25 | $177.3M | $13.5M | ||
| Q2 25 | $185.4M | $11.7M | ||
| Q1 25 | $174.6M | — | ||
| Q3 24 | $20.9M | — | ||
| Q2 24 | $20.6M | — | ||
| Q1 24 | $37.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-6.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-2.7M | $-6.5M | ||
| Q2 25 | $-482.6K | $-4.8M | ||
| Q1 25 | $-64.1K | — | ||
| Q3 24 | $-686.5K | — | ||
| Q2 24 | $-483.2K | — | ||
| Q1 24 | $-498.8K | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OSRH
Segment breakdown not available.
PMI
| Products | $1.1M | 94% |
| Other | $72.0K | 6% |
